Scotiabank Cuts Sociedad Química y Minera de Chile (NYSE:SQM) Price Target to $45.00

Sociedad Química y Minera de Chile (NYSE:SQM - Free Report) had its target price reduced by Scotiabank from $50.00 to $45.00 in a report issued on Friday morning,Benzinga reports. They currently have a sector outperform rating on the basic materials company's stock. Scotiabank also issued estimates for Sociedad Química y Minera de Chile's Q2 2025 earnings at $0.56 EPS, FY2025 earnings at $2.63 EPS and FY2026 earnings at $3.76 EPS.

Separately, BMO Capital Markets dropped their price target on shares of Sociedad Química y Minera de Chile from $55.00 to $45.00 and set an "outperform" rating for the company in a research note on Thursday, May 29th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $41.86.

Sociedad Química y Minera de Chile Trading Up 2.7%

SQM stock traded up $0.80 during midday trading on Friday, hitting $30.83. 440,913 shares of the company's stock were exchanged, compared to its average volume of 1,120,060. Sociedad Química y Minera de Chile has a 1-year low of $29.36 and a 1-year high of $47.10. The company has a current ratio of 2.94, a quick ratio of 2.05 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $8.81 billion, a PE ratio of -27.77, a P/E/G ratio of 5.00 and a beta of 1.11. The business has a 50-day simple moving average of $34.85 and a two-hundred day simple moving average of $37.82.

Sociedad Química y Minera de Chile (NYSE:SQM - Get Free Report) last posted its quarterly earnings data on Wednesday, May 28th. The basic materials company reported $0.48 earnings per share for the quarter, missing analysts' consensus estimates of $0.63 by ($0.15). The company had revenue of $1.04 billion for the quarter, compared to analysts' expectations of $1.05 billion. Sociedad Química y Minera de Chile had a positive return on equity of 16.12% and a negative net margin of 6.74%. The business's revenue for the quarter was down 4.4% on a year-over-year basis. During the same period in the previous year, the business posted ($3.04) EPS. On average, sell-side analysts predict that Sociedad Química y Minera de Chile will post -1.31 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Brooklyn Investment Group lifted its position in shares of Sociedad Química y Minera de Chile by 61,700.0% during the 1st quarter. Brooklyn Investment Group now owns 618 shares of the basic materials company's stock worth $25,000 after purchasing an additional 617 shares during the last quarter. Banque Cantonale Vaudoise acquired a new stake in Sociedad Química y Minera de Chile in the first quarter valued at $34,000. Kestra Investment Management LLC purchased a new stake in Sociedad Química y Minera de Chile during the 4th quarter worth about $39,000. Jones Financial Companies Lllp lifted its holdings in Sociedad Química y Minera de Chile by 803.4% during the 4th quarter. Jones Financial Companies Lllp now owns 1,075 shares of the basic materials company's stock worth $39,000 after buying an additional 956 shares during the last quarter. Finally, Grove Bank & Trust acquired a new position in shares of Sociedad Química y Minera de Chile during the 1st quarter worth about $46,000. Hedge funds and other institutional investors own 12.41% of the company's stock.

About Sociedad Química y Minera de Chile

Sociedad Química y Minera de Chile SA operates as a mining company worldwide. The company offers specialty plant nutrients, including sodium potassium nitrate, specialty blends, and other specialty fertilizers under Ultrasol, Qrop, Speedfol, Allganic, Ultrasoline, ProP, and Prohydric brands. It also provides iodine and its derivatives for use in medical, agricultural, industrial, and human and animal nutrition products comprising x-ray contrast media, biocides, antiseptics and disinfectants, pharmaceutical intermediates, polarizing films for LCD and LED screens, chemicals, organic compounds, and pigments, as well as added to edible salt to prevent iodine deficiency disorders.